InvestorsObserver
×
News Home

Should You Add Chembio Diagnostics Inc (CEMI) Stock to Your Portfolio Friday?

Friday, October 01, 2021 11:06 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Chembio Diagnostics Inc (CEMI) Stock to Your Portfolio Friday?

The 49 rating InvestorsObserver gives to Chembio Diagnostics Inc (CEMI) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 75 percent of stocks in the Healthcare sector, CEMI’s 49 overall rating means the stock scores better than 49 of all stocks.

Overall Score - 49
CEMI has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on CEMI!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Chembio Diagnostics Inc Stock Today?

Chembio Diagnostics Inc (CEMI) stock has fallen -2.4% while the S&P 500 is up 0% as of 11:05 AM on Friday, Oct 1. CEMI has fallen -$0.06 from the previous closing price of $2.50 on volume of 462,743 shares. Over the past year the S&P 500 has gained 27.41% while CEMI has fallen -49.69%. CEMI lost -$1.30 per share the over the last 12 months. Click Here to get the full Stock Report for Chembio Diagnostics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App